Press release
Agrigenomics Market Driving Factors & COVID-19 Impact on the Global Market
The global agrigenomics market is estimated at USD 3.3 billion in 2021 and is projected to reach USD 5.3 billion by 2026, at a CAGR of 9.7% from 2021 to 2026.The utilization of genomics solutions for crops can lead to the development of specific crop varieties exhibiting resistance to different diseases, drought tolerance, nutritional enrichment, and high quality. Gene editing can provide a sustainable way in the mass production of desired crops by eliminating the traits hampering widespread production.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206614334
Genomics in livestock production can lead to a better understanding of the genetic risk in animals, thereby adapting to measures for future profitability. Animal genomics empowers livestock producers with strategic animal selection and breeding decisions to optimize profitability and yield enhancement of livestock herds.
The global agrigenomics market is majorly fueled by rapid advances in the functional genomics sector with the adaptation of massively parallel sequencing technologies and the development of protocols to efficiently analyze cellular behavior at the molecular level. For applied genomics in agriculture, molecular marker-assisted crop breeding has proved effective over conventional breeding programs, with regard to the increasing scope, speed, and efficiency of crop selection. Advanced genome characterization techniques have shown increased quality and yield of crops at the same time requiring less fertilizers, pesticides, and water. For livestock, the novel technologies are known to greatly improvise the desirable traits, such as milk yield, meat quality, and reproductive life.
COVID-19 impact on the Agrigenomics Market:
The outbreak of COVID-19 has brought serious medical, social, and economic challenges. Where the medical community is focused on developing successful diagnostic and medical treatment, the agricultural & food processing industries are channelizing their efforts to restore efficient food production, logistics and supply chain efficiency, and creating buffer systems to absorb future supply-demand shocks.
Apart from commodities producers & suppliers, seed manufacturers, trait developers, and genomics researchers alike are focusing to bring solutions for capacity-building in the wake of the COVID-19 pandemic. Agricultural genomics is advancing in the direction of harnessing gene-editing techniques to develop a plethora of anti-bacterial, anti-fungal, and anti-viral solutions
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=206614334
North America dominated the agrigenomics market due to the strong R&D, technology innovation, and increased mergers and acquisitions in agrigenomics in the region. The US accounted for the largest country-level share in 2020 due to the advancements in sequencing and molecular breeding that are used in applications such as food & agriculture, animal health, and public health.
The key players in this market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Illumina, Inc. (US), Eurofins Scientific SE (Luxembourg), and LGC Limited (UK). Some of these players–Thermo Fisher Scientific, Inc. (US) and Illumina, Inc. (US)–are both, technology and service providers who have streamlined their supply chain in providing agrigenomics services.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Agrigenomics Market Driving Factors & COVID-19 Impact on the Global Market here
News-ID: 2378204 • Views: …
More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624
These fertilizers are prized for their ability…

Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,…

Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%.
Download PDF Brochure:…

Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…